Abstract:The biological behaviors of residual hepatoma cells after transarterial embolization therapy, which exist in a hypoxic or even anaerobic tumor microenvironment, differ from the tumor cells under normoxic conditions. This study aimed to use a phage display peptide library for in vivo and in vitro screening to obtain a peptide which could specifically bind to hypoxic hepatoma cells, allowing further targeted diagnosis and treatment for liver cancer. In this study, hypoxic hepatoma cells HepG2 (targeted cells), and normal liver cells HL-7702 (control cells), were utilized to perform three rounds of in vitro screening using a phage-displayed 7-mer peptide library. In addition, hypoxic HepG2 were subcutaneously injected into nude mice to establish a hepatocarcinoma model, followed by performing three rounds of in vivo screening on the phages identified from the in vitro screening. The products from the screening were further identified using ELISA and immunofluorescence staining on cells and tissues. The results indicated that the P11 positive clone had the highest binding effect with hypoxic hepatoma cells. The sequence of the exogenous insert fragment of P11 positive clone was obtained by sequencing: GSTSFSK. The binding assay indicated that GSTSFSK could specifically bind to hypoxic hepatoma cells and hepatocarcinoma tissues. This 7-mer peptide has the potential to be developed as an useful molecular to the targeting diagnosis and treatment of residual hepatoma cells after transarterial chemoembolization.

Screening and Characterization of Multi-Peptide Binding Specifically to Hepatocellular Carcinoma Cells by Phage Peptide Library

Screening and identification of hepatocellular carcinoma cell specific binding peptides using phage display peptide library

Screening and Identification of A Targeting Peptide to Hepatocarcinoma from A Phage Display Peptide Library

Screening and Identification of Polypeptides Specifically Binding to Hepatoma Carcinoma Cells

Screening and Characterization of Multipeptide Binding Specifically to Gastric Cancer Cells by Phage Peptide Library

[Phage Display Random Peptide Library for Screening the Peptides That Specifically Bind to Hepatocellular Carcinoma Cells].

Screening and Identification of a Specific Peptide Binding to Hepatocellular Carcinoma Cells from a Phage Display Peptide Library

Selection and Preliminary Identification of Hepatocarcinoma-Binding and Internalizing Peptide

Selection of the Peptides Specifically Binding to Hepatoma by Using Phage Display in Vivo

THE FURTHER CHARACTERIZATION OF THE SPECIFICALLY BINDING PEPTIDE TO HEPATOCELLULAR CARCINOMA

Screening of Proteins Binding with Human CD8+T Lymphocytes with T7 Select Human Hepatoma cDNA Library

In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library.

Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma

Research on Screening Peptides Specifically Targeting Laryngeal Squamous Cell Carcinoma by Phage Display Technique

Ph.D. -C7CTM Phage Display Peptide Library Selection on Gastric Cancer MDR Cells to Yield Specific Binding Peptides

Identification and Localization of Hepatocarcinoma-Specific Adhesion Peptide

In Vivo Screening with Ph . D .7 TM and Identification of Ovarian Cancer A 2780 Cell Targeted

Screening and identification of a specific peptide for targeting hypoxic hepatoma cells

Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library

Screening for serum binding proteins in subjects with primary hepatocellular carcinoma using a phage display system

Screening of Human Phage Antibodies with Single-Chain Variable Fragment and Identiflication of Its Specificity to Liver Cancer Cells